Chemotherapy Medication Error Prevention
Contents |
CME CME Activities My CME Search for Keyword: GO Advanced Search User Name Password Sign In Advertisement Preventing Chemotherapy Errors Lisa Schulmeister Lisa Schulmeister, preventing medication errors in cancer chemotherapy R.N., M.N., C.S., O.C.N.®, 282 Orchard Road, River Ridge, Louisiana 70123-2648,
Chemotherapy Medication Errors Descriptions Severity And Contributing Factors
USA. Telephone: 504-739-9462 (work), 504-737-7540 (home); Fax: 504-738-2087; e-mail: LisaSchulmeister{at}hotmail.com Received March 14, 2005. Accepted March 30, 2006.
Medication Error Prevention For Nurses
Learning Objectives After completing this course, the reader will be able to: Define the extent and scope of chemotherapy errors and their impact on patient care. Describe common
Medication Error Prevention Strategies
types of prescribing errors. Recommend procedures to prevent errors in drug orders, preparation, and identification of patients. Identify reporting and monitoring systems both within your institution and at the government levels. Access and take the CME test online and receive 1 AMA PRA category 1 credit at CME.TheOncologist.com Next Section Abstract A large amount of information on chemotherapy medication error prevention powerpoint error prevention is available to the practicing oncologist. However, few oncologists have the time and resources to obtain the information and evaluate the evidence. Further, much of the information is generic and does not provide specific direction on how the information can be applied in clinical practice. This manuscript reviews principles of safe chemotherapy administration, identifies key actions to prevent chemotherapy errors, and provides suggestions on how the information can be incorporated into daily practice. Chemotherapy administration Safety Error reporting Previous SectionNext Section Introduction Your morning was unexpectedly busy. Traffic was backed up on the way to the hospital. The emergency consult for anemia has leukemic cells on the peripheral smear. Now you are rushing to the office but first have to take care of Judy Smith. Judy was admitted for treatment of refractory lymphoma and is anxious about receiving her treatment in the hospital. She read hospital errors result in more deaths than a crash of a jumbo jet every day and that 44,000–98,000 patients per year die of medical er
Alerts Search this journal Advanced Journal Search » Ranking: 2015 SJR (SCImago Journal Rank) Score: 0.443 | 134/252 Pharmacology (medical) (Scopus®) | Indexed in medication error prevention videos MEDLINE/PubMed Prevention of Chemotherapy Medication Errors Dwight D. Kloth, PharmD, FCCP, BCOP medication error prevention initiative Department of Medical Oncology, Department of Pharmacy, Room H4-128, Fox Chase Cancer Center, 7701 Burholme Ave, Philadelphia, PA 19111, medication error prevention for healthcare providers dd_kloth{at}fccc.edu Abstract Prevention of medication errors has long been a concern of pharmacists in all practice settings, including specialty treatment and research centers. Oncology pharmacists have always been particularly aware of this http://theoncologist.alphamedpress.org/content/11/5/463.full concern because many of the cytotoxic drug therapy regimens we use are already at the maximum tolerated doses, thus leaving no margin for error. During the past 10 years, catastrophic chemotherapy medication errors have occurred in some of the finest hospitals and cancer centers in the United States, bringing unprecedented public and governmental awareness of the risk of such errors. In addition, the March http://jpp.sagepub.com/content/15/1/17.short 2000 report by the Institute of Medicine of the National Academy of Sciences, To Err Is Human: Building a Safer Health System, has prompted legislative and executive branch reaction at the federal level aimed toward reducing medical errors of all types, including medication errors. The purpose of this article is to review the types and causes of catastrophic chemotherapy medication errors that have occurred in oncology and to discuss tools and methods aimed at improving the safety of medication use, particularly chemotherapy, in the United States. cancer chemotherapy errors medication errors preventable prevention safety CiteULike Connotea Delicious Digg Facebook Google+ LinkedIn Mendeley Reddit StumbleUpon Twitter What's this? « Previous | Next Article » Table of Contents This Article doi: 10.1106/EXK5-5F5M-T5QV-45CW Journal of Pharmacy Practice February 2002 vol. 15 no. 1 17-31 » Abstract Full Text (PDF) References Services Email this article to a colleague Alert me when this article is cited Alert me if a correction is posted Similar articles in this journal Download to citation manager Request Permissions Request Reprints Load patientINFORMation Citing Articles Load citing article information Citing articles via Scopus Citing articles via Web of Scienc
L Green, RJ Muller and JM Pruemer Abstract Recommendations for preventing medication errors in cancer chemotherapy are made. Before http://www.ajhp.org/content/53/7/737 a health care provider is granted privileges to prescribe, dispense, or administer antineoplastic agents, he or she should undergo a tailored educational program and possibly testing or certification. Appropriate reference materials should be developed. Each institution should develop a dose-verification process with as many independent checks as possible. A detailed checklist covering prescribing, medication error transcribing, dispensing, and administration should be used. Oral orders are not acceptable. All doses should be calculated independently by the physician, the pharmacist, and the nurse. Dosage limits should be established and a review process set up for doses that exceed the limits. These limits should be entered into pharmacy computer systems, medication error prevention listed on preprinted order forms, stated on the product packaging, placed in strategic locations in the institution, and communicated to employees. The prescribing vocabulary must be standardized. Acronyms, abbreviations, and brand names must be avoided and steps taken to avoid other sources of confusion in the written orders, such as trailing zeros. Preprinted antineoplastic drug order forms containing checklists can help avoid errors. Manufacturers should be encouraged to avoid or eliminate ambiguities in drug names and dosing information. Patients must be educated about all aspects of their cancer chemotherapy, as patients represent a last line of defense against errors. An interdisciplinary team at each practice site should review every medication error reported. Pharmacists should be involved at all sites where antineoplastic agents are dispensed. Although it may not be possible to eliminate all medication errors in cancer chemotherapy, the risk can be minimized through specific steps. Because of their training and experience, pharmacists should take
be down. Please try the request again. Your cache administrator is webmaster. Generated Tue, 04 Oct 2016 15:55:22 GMT by s_hv972 (squid/3.5.20)